Simplify Asset Management Inc. purchased a new position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 306,590 shares of the biotechnology company’s stock, valued at approximately $463,000. Simplify Asset Management Inc. […]
Atreca (NASDAQ:BCEL) Cut to Neutral at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
CymaBay Therapeutics (NASDAQ:CBAY – Free Report) had its price target raised by BTIG Research from $18.00 to $22.00 in a research report sent to investors on Friday, MarketBeat reports. BTIG Research currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on CBAY. Guggenheim initiated coverage […]
Chardan Capital reaffirmed their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a research note published on Wednesday, Benzinga reports. The firm currently has a $11.00 price target on the stock. Separately, BTIG Research assumed coverage on shares of Coya Therapeutics in a research note on Thursday, May 18th. They issued […]
Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) General Counsel William M Haskel Sells 34,526 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.